Dani Castillo, Medical Oncologist, Researcher at City of Hope shared on X:
“Very informative session on Concepts in Precision Oncology chaired by Dr. Oh discussions on next-generation ADC strategies, innovative clinical trial designs, and how precision medicine continues to reshape oncology drug development.”
You may also be interested in: WUTSUP-02 Trial: ADC–Immunotherapy in Perioperative Treatment of UTUC
